Biotechnology Industry Market Index
The Biotechnology Industry in the Health Care Sector includes companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering (including companies specializing in protein-based therapeutics to treat human diseases).
The Biotechnology industry index is a market composite index that includes 8 stocks from public trading companies and ADRs with the largest market capitalizations in the Biotechnology industry.
The list of stocks in the Biotechnology industry includes Moderna Inc., Gilead Sciences Inc, AbbVie Inc, Vertex Pharmaceuticals Inc, Amgen Inc, Regeneron Pharmaceuticals Inc, Incyte Corp and Biogen Inc.
3/27/2025 Health Care Sector Biotechnology Industry
$371,443
Change: +0.54%
Open: $370,384
High: $373,972
Low: $368,464
| Moderna Inc. (MRNA) |
+2.03%
|
| Gilead Sciences Inc (GILD) |
+1.73%
|
| AbbVie Inc (ABBV) |
+0.71%
|
| Biotechnology Industry |
+0.54%
|
| Vertex Pharmaceuticals Inc (VRTX) |
+0.45%
|
| Amgen Inc (AMGN) |
+0.02%
|
| Regeneron Pharmaceuticals Inc (REGN) |
-0.67%
|
| Incyte Corp (INCY) |
-0.95%
|
| Biogen Inc (BIIB) |
-1.47%
|
Index Value: $371,443 +0.54%
Volume: 7.38B Average Volume (3 month): 11.88B
Market Capitalization: $287.13T
EBITDA: $26.70T
PEG Ratio (5 year Expected): 6.57
Dividend Yield: 2.20%
Dividend Rate: $6,777
Dividend Yield (Forward): 2.30%
Dividend Rate (Forward): $7,097
Shares Outstanding: 1.91T
Book Value: $42,386
Short Ratio: 2.61
Price Target (1 year): $322,548
Volume: 7.38B Average Volume (3 month): 11.88B
Market Capitalization: $287.13T
EBITDA: $26.70T
PEG Ratio (5 year Expected): 6.57
Dividend Yield: 2.20%
Dividend Rate: $6,777
Dividend Yield (Forward): 2.30%
Dividend Rate (Forward): $7,097
Shares Outstanding: 1.91T
Book Value: $42,386
Short Ratio: 2.61
Price Target (1 year): $322,548
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| MRNA | Moderna Inc. | 32.12 | +2.03% | 6.19M | 0.54 | 1.37% |
| GILD | Gilead Sciences Inc | 111.16 | +1.73% | 6.29M | 0.74 | 15.34% |
| ABBV | AbbVie Inc | 202.72 | +0.71% | 3.37M | 0.54 | 39.65% |
| Biotechnology Industry | 371,443.39 | +0.54% | 7.38B | 0.62 | 13.87% | |
| VRTX | Vertex Pharmaceuticals Inc | 502.55 | +0.45% | 1.23M | 0.84 | 14.30% |
| AMGN | Amgen Inc | 305.77 | +0.02% | 1.73M | 0.55 | 18.20% |
| REGN | Regeneron Pharmaceuticals Inc | 635.83 | -0.67% | 804,023 | 0.86 | 7.57% |
| INCY | Incyte Corp | 60.68 | -0.95% | 1.24M | 0.70 | 1.30% |
| BIIB | Biogen Inc | 140.33 | -1.47% | 1.31M | 0.84 | 2.28% |
| Symbol | Security | Market Cap | Div Yield | PEG Ratio |
| MRNA | Moderna Inc. | 14.35B | ||
| GILD | Gilead Sciences Inc | 109.36B | 3.46% | |
| ABBV | AbbVie Inc | 294.353B | 3.73% | |
| Biotechnology Industry | $287.13T | 2.20% | 6.57 | |
| VRTX | Vertex Pharmaceuticals Inc | 115.376B | ||
| AMGN | Amgen Inc | 153.1B | 3.19% | |
| REGN | Regeneron Pharmaceuticals Inc | 81.266B | ||
| INCY | Incyte Corp | 13.593B | ||
| BIIB | Biogen Inc | 22.943B | ||
Back to Market Summary